hat is a potential challenge in gene therapy related to immune response?a.Immune rejection of the therapeutic vectorb.Rapid degradation of therapeutic genesc.Lack of therapeutic genesd.Overexpression of target genes

The potential challenge in gene therapy related to immune response is the immune rejection of the therapeutic vector.

Here's a step-by-step explanation:

1. Gene therapy involves the introduction of foreign genetic material into a patient's cells to treat or prevent disease. This is often done using a vector, which is usually a virus that has been genetically modified to carry the therapeutic gene.

2. The immune system's job is to protect the body from foreign invaders, such as viruses. Therefore, when a therapeutic vector is introduced into the body, the immune system may recognize it as foreign and mount an immune response against it.

3. This immune response can lead to the destruction of the therapeutic vector before it has a chance to deliver the therapeutic gene to the target cells. This is known as immune rejection of the therapeutic vector.

4. Immune rejection of the therapeutic vector is a significant challenge in gene therapy because it can prevent the therapy from working. Researchers are working on ways to overcome this challenge, such as by developing vectors that can evade the immune system or by using immunosuppressive drugs to dampen the immune response during gene therapy.